Moderna's mRNA flu shot earns FDA approval after rollercoaster review
- ID
- 11695
- Status
- summarized
- Published
- 07 Aug 2026, 12:31 AM
- Fetched
- 07 Aug 2026, 2:56 AM
- Provider
- Ars Technica
- Category
- technology
- Original URL
- https://arstechnica.com/health/2026/08/modernas-mrna-flu-shot-earns-fda-approval-after-rollercoaster-review/
- Source URL
- https://feeds.arstechnica.com/arstechnica/index
Excerpt
Moderna's new flu vaccine, mFLUSIVA, is approved for all adults ages 50 and up.
Summary
No summary yet. It will appear after the daemon summarizes this item.